Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT03786354
What this trial is testing

Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+12 more
Ohio State University Comprehensive Cancer Center 61
Large-scale testing (Phase 3)WithdrawnNCT00693342
What this trial is testing

Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group
Not applicableStudy completedNCT00869466
What this trial is testing

Weight Control Programs in Women Who Have Undergone Surgery for Early Stage Breast Cancer

Who this might be right for
Breast CancerWeight Changes
Wythenshawe Hospital 409
Early research (Phase 1)Study completedNCT02217956
What this trial is testing

Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma

Who this might be right for
Ovarian AdenocarcinomaFallopian Tube AdenocarcinomaPrimary Peritoneal Carcinoma
Gustave Roussy, Cancer Campus, Grand Paris 30
Testing effectiveness (Phase 2)Study completedNCT00499083
What this trial is testing

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Who this might be right for
Breast Cancer
University of Nebraska 17
Early research (Phase 1)Study completedNCT02389751
What this trial is testing

Ganetespib in Combination With Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-III Esophageal Cancer

Who this might be right for
Gastroesophageal Junction AdenocarcinomaMalignant Neoplasm of the Cervical EsophagusMalignant Neoplasm of the Thoracic Esophagus+5 more
M.D. Anderson Cancer Center 3
Very early researchStudy completedNCT02320305
What this trial is testing

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

Who this might be right for
Stage IIA Skin MelanomaStage IIB Skin MelanomaStage IIC Skin Melanoma+4 more
Mayo Clinic 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT03428802
What this trial is testing

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

Who this might be right for
BRCA1 Gene MutationBRCA2 Gene MutationLocally Advanced Solid Neoplasm+17 more
Rutgers, The State University of New Jersey 21
Testing effectiveness (Phase 2)Ended earlyNCT00088829
What this trial is testing

Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer

Who this might be right for
Breast Cancer
Georgetown University 22
Testing effectiveness (Phase 2)Ended earlyNCT02414750
What this trial is testing

Vemurafenib Plus Cobimetinib in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Netherlands Working Group on Immunotherapy of Oncology 78
Not applicableStudy completedNCT01982591
What this trial is testing

Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Who this might be right for
Male Breast CancerNeurotoxicityPeripheral Neuropathy+6 more
Fox Chase Cancer Center 115
Not applicableLooking for participantsNCT06167460
What this trial is testing

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

Who this might be right for
Non Small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung Cancer+2 more
Gene Solutions 50
Testing effectiveness (Phase 2)Study completedNCT01950390
What this trial is testing

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Stage IIIC Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7Unresectable Melanoma
National Cancer Institute (NCI) 169
Testing effectiveness (Phase 2)UnknownNCT00659113
What this trial is testing

S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery

Who this might be right for
Esophageal Cancer
Yonsei University 32
Large-scale testing (Phase 3)Active Not RecruitingNCT00433420
What this trial is testing

Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 2,000
Not applicableActive Not RecruitingNCT04454450
What this trial is testing

Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer

Who this might be right for
Ovarian CancerHigh Grade Ovarian Serous
Memorial Sloan Kettering Cancer Center 10
Early research (Phase 1)Study completedNCT02019524
What this trial is testing

Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients

Who this might be right for
Breast CancerOvarian Cancer
COL George Peoples, MD, FACS 39
Not applicableStudy completedNCT01217385
What this trial is testing

Monitoring and Predicting Chemotherapy Response Using DOSI

Who this might be right for
Breast Cancer
American College of Radiology Imaging Network 60
Testing effectiveness (Phase 2)Ended earlyNCT00343512
What this trial is testing

Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT02827877
What this trial is testing

Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer

Who this might be right for
HER2 Positive Breast CarcinomaStage IIIA Breast CancerStage IIIB Breast Cancer+1 more
City of Hope Medical Center 18
Next Page